People_

Professor Annette Haworth

FACPSEM, PhD (UWA), MSc (UWA), BSc(Hons, Leeds, UK)

Professor of Medical Physics
Director, Institute of Medical Physics

Phone

+61 2 8627 5457

annette.haworth@sydney.edu.au

Address

A28 - Physics Building

The University of Sydney

Details

Member of The University of Sydney Nano Institute

Resume

Curriculum vitae

Biographical details

Prof Haworth is an ACPSEM accredited medical physicist with more than 25 years hospital based, clinical medical physics experience. She has held the Chair of Medical Physics role at the University of Sydney since 2016. Annette is the Director of the Institute of Medical Physics and the course director for the Master of Medical Physics course. Since August 2023 Prof Haworth has also held the conjoint role of Director, Radiation Oncology Medical Physics at Westmead and Blacktown Hospitals. With proud links to the University of Sydney, both hospitals provide a full range of high-quality radiation therapy treatments and are actively engaged in further developing their reputation as a world leaders in radiation oncology related research and development.

Research interests

I lead a team of physicists, computer scientists, doctors, surgeons and pathologists are working together to devise radiation therapy treatments that are tailored to the specific patient. Unlike other treatments where the same radiation dose is delivered to all patients with the same type of tumour, our goal is customise the radiation dose to the specific patient, not the specific tumour. We want to deliver just the right amount of radiation to cure each cancer without causing lasting side effects. Our team is working on methods using AI and medical imaging techniques to define the biological distribution of cells in a cancer. We want to design and deliver radiation treatments whereby only the treatment resistant cells get very large doses of radiation, whilst the less aggressive cells get lower doses. This way we can maximise the chances of effectively treating the cancer whilst minimising the radiation dose, and hence harm, to the healthy surrounding tissue.

Teaching and supervision

Research Student	Project title	Institution
Elizabeth Claridge Mackonis (PhD)	A Framework for the Safe and Effective Implementation of New Technology for Radiation Oncology	University of Sydney
Taka Hiok (PhD)	Towards a personalisedtheranosticsplatform through an improved understanding of the biological effects of radionuclide therapy	University of Sydney
Arpita Dutta (PhD)	Development of imaging biomarkers to evaluate treatment response in patients undergoing prostate cancer radiotherapy	University of Auckland
Yutong Zhao (PhD)	Practical implementation of prostate cancer radiotherapy based on tumour biological characterization	University of WA (completed February 2024)
Jaysree Ukath(PhD)	Four-dimensional verification of moving targets in radiation therapy	University of Sydney
Michael Lloyd (PhD)	Investigations into Impact and Utilisation of Secondary Hadrons in Particle Therapy.	University of Sydney
Mahesh Chandroth (PhD)	Development of a bone equivalent normoxic polymer gel for dosimetric verification in radiation oncology.	University of Sydney
Thi Hoang Anh Le (Annie) (PhD)	Developing a personalized approach to radiation therapy using 3D-printed bolus	University of Sydney
Kazi Ridita Mahtaba (PhD)	A Biologically Targeted Approach for Optimizing Salvage Radiotherapy of Recurrent Prostate Cancer	University of Sydney
Fidel Navarro Salazar (PhD)	Novel radiation therapeutic approaches using functional imaging for poor prognosis primary liver cancer.	University of Sydney
Him Chan	Using PSMA PET/CT and artificial intelligence to detect prostate cancer and assess treatment response to radiation therapy	University of Auckland
Danielle Chrystall (PhD)	Development and clinical evaluation of Direct Beam-view Tracking: A real-time motion management strategy that uses artificial intelligence to automatically segment fiducial markers in beam’s eye view images in radiation therapy.	University of Sydney

Current projects

https://birt.sydney.edu.au

Associations

Fellow, Australasian College of Physical Scientists in Medicine

Member, Australasian Brachytherapy Group (Chair 2013-2015)

Member, ESTRO

Member, IMP

Member, TROG (Life membership awarded 2018)

Awards and honours

In 2021 Prof Haworth was awared a University of Sydney DVCR Cancer Gift, providing salary support for a five-year period to pursue her imprtant work in cancer research. In 2015 Prof Haworth was awarded the prestigious Judith Stitt Award, by the American Brachytherapy Society. In 2007 she received the inaugural TROG Outstanding Achievement Award having served as the TROG physicist and member of the Scientific Committee 2003–2011 and was awarded Life Membership in in 2018. Annette is a past chair of the Australasian Brachytherapy Group and has received multiple awards for her work in the area of prostate brachytherapy.

Current research students

Project title	Research student
Bone marrow sparing extended-field radiation therapy for gynaecological cancers to reduce haematological toxicity	Gemma BUSUTTIL
Improving the Implementation of New Technology for Radiation Oncology	Elizabeth CLARIDGE MACKONIS
Developing a personalized approach to radiation therapy using 3D-printed bolus	Annie LE
A Biologically Targeted Approach for Optimizing Salvage Radiotherapy of Recurrent Prostate Cancer	Kazi Ridita MAHTABA
Novel radiation therapeutic approaches using functional imaging for poor prognosis primary liver cancer.	Fidel NAVARRO SALAZAR
Four-dimensional verification of moving targets in radiation therapy	Jaysree UKATH

Publications

By Type

Expand all

Book Chapters

Haworth, A., Ibbott, G. (2013). Medical Physics for Clinical Trials. In Jacob Van Dyk (Eds.), The Modern Technology of Radiation Oncology, Vol 3, (pp. 487-510). Madison, WI, United States: Medical Physics.
Hickey-Moody, A., Haworth, R. (2009). Affective Literacies. In Masny, Diana; Cole, David R (Eds.), Multiple Literacies Theory: A Deleuzian Perspective, (pp. 79-91). Rotterdam, Netherlands: Sense Publishers. [More Information]

Journals

Wigg, A., Tibballs, J., Woodman, R., Stuart, K., Le, H., Roberts, S., Olynyk, J., Strasser, S., Wallace, M., Martin, J., Haworth, A., et al (2024). A randomised controlled trial of Standard Of Care versus RadioAblaTion in Early Stage HepatoCellular Carcinoma (SOCRATES HCC). BMC Cancer, 24(1). [More Information]
Le Bao, V., Cloak, K., Sidhom, M., Kneebone, A., Holloway, L., Haworth, A., Dowling, J., Walker, A., Arumugam, S., Jameson, M., et al (2024). Evaluating the relationship between contouring variability and modelled treatment outcome for prostate bed radiotherapy. Physics in Medicine and Biology, 69(8), 085008. [More Information]
Claridge Mackonis, E., Haworth, A., Stensmyr, R., Poldy, R., White, P., Moutrie, Z., Gorjiara, T., Seymour, E., Erven, T., Hardcastle, N. (2024). Improving motion management in radiation therapy: findings from a workshop and survey in Australia and New Zealand. Physical and Engineering Sciences in Medicine. [More Information]
Phillips, C., Pinkham, M., Moore, A., Sia, J., Jeffree, R., Khasraw, M., Kam, A., Bressel, M., Haworth, A. (2024). Local hero: A phase II study of local therapy only (stereotactic radiosurgery and / or surgery) for treatment of up to five brain metastases from HER2+ breast cancer. (TROG study 16.02). Breast, 74, 103675. [More Information]
Dutta, A., Chan, J., Haworth, A., Dubowitz, D., Kneebone, A., Reynolds, H. (2024). Robustness of magnetic resonance imaging and positron emission tomography radiomic features in prostate cancer: Impact on recurrence prediction after radiation therapy. Physics And Imaging In Radiation Oncology, 29. [More Information]
Zhao, Y., Haworth, A., Reynolds, H., Williams, S., Finnegan, R., Rowshanfarzad, P., Ebert, M. (2024). Towards optimal heterogeneous prostate radiotherapy dose prescriptions based on patient-specific or population-based biological features. Medical Physics. [More Information]
Chlap, P., Tran, P., Kron, T., Sidhom, M., Wiltshire, K., Keats, S., Kneebone, A., Haworth, A., Ebert, M., Vinod, S., Holloway, L., et al (2024). Uncertainty estimation using a 3D probabilistic U-Net for segmentation with small radiotherapy clinical trial datasets. Computerized Medical Imaging and Graphics, 116, 102403. [More Information]
Claridge Mackonis, E., Hardcastle, N., Haworth, A. (2023). A survey of compliance with stereotactic ablative body radiotherapy quality recommendations. Journal of Medical Imaging and Radiation Oncology. [More Information]
Beaulieu, L., Ballester, F., Granero, D., Tedgren, Å., Haworth, A., Lowenstein, J., Ma, Y., Mourtada, F., Papagiannis, P., Rivard, M., et al (2023). AAPM WGDCAB Report 372: A joint AAPM, ESTRO, ABG, and ABS report on commissioning of model-based dose calculation algorithms in brachytherapy. Medical Physics, 50(8), e946-e960. [More Information]
Min, H., Dowling, J., Jameson, M., Cloak, K., Faustino, J., Sidhom, M., Martin, J., Cardoso, M., Ebert, M., Haworth, A., Holloway, L., et al (2023). Clinical target volume delineation quality assurance for MRI-guided prostate radiotherapy using deep learning with uncertainty estimation. Radiotherapy and Oncology, 186. [More Information]
Chan, T., Haworth, A., Wang, A., Osanlouy, M., Williams, S., Mitchell, C., Hofman, M., Hicks, R., Murphy, D., Reynolds, H. (2023). Detecting localised prostate cancer using radiomic features in PSMA PET and multiparametric MRI for biologically targeted radiation therapy. EJNMMI Research, 13(34), 1-14.
Zhao, Y., Haworth, A., Rowshanfarzad, P., Ebert, M. (2023). Focal Boost in Prostate Cancer Radiotherapy: A Review of Planning Studies and Clinical Trials. Cancers, 15(19). [More Information]
Davoudi, F., Batra, J., Moradi, A., Becker, T., Lock, J., Abbey, B., Fontanarosa, D., Haworth, A., Clements, J., Ecker, R. (2023). Genomic and Phenotypic Biomarkers for Precision Medicine Guidance in Advanced Prostate Cancer. Current Treatment Options in Oncology, 24(10), 1451-1471. [More Information]
Zhao, Y., Haworth, A., Reynolds, H., Her, E., Sun, Y., Finnegan, R., Rowshanfarzad, P., Ebert, M. (2023). Patient-specific voxel-level dose prescription for prostate cancer radiotherapy considering tumor cell density and grade distribution. Medical Physics. [More Information]
Poder, J., Rivard, M., Howie, A., 60025709, C., Haworth, A. (2023). Risk and Quality in Brachytherapy From a Technical Perspective. Clinical Oncology. [More Information]
Thwaites, D., Prokopovich, D., Garrett, R., Haworth, A., Rosenfeld, A., Ahern, V. (2023). The rationale for a carbon ion radiation therapy facility in Australia. Journal of Medical Radiation Sciences. [More Information]
Montazerolghaem, M., Sun, Y., Sasso, G., Haworth, A. (2023). U-Net Architecture for Prostate Segmentation: The Impact of Loss Function on System Performance. Bioengineering, 10(412), 1-19. [More Information]
Claridge Mackonis, E., Sykes, J., Hardcastle, N., Espinoza, A., Brown, A., Perez, G., Evans, B., Sheehan, H., Haworth, A. (2022). A comparison of in-house and shared RapidPlan models for prostate radiation therapy planning. Physical and Engineering Sciences in Medicine, 45(4), 1029-1041. [More Information]
Finnegan, R., Reynolds, H., Ebert, M., Sun, Y., Holloway, L., Sykes, J., Dowling, J., Mitchell, C., Williams, S., Murphy, D., Haworth, A. (2022). A statistical, voxelised model of prostate cancer for biologically optimised radiotherapy. Physics And Imaging In Radiation Oncology, 21, 136-145. [More Information]
Pudsey, L., Haworth, A., White, P., Moutrie, Z., Jonker, B., Foote, M., Poder, J. (2022). Current status of intra-cranial stereotactic radiotherapy and stereotactic radiosurgery in Australia and New Zealand: key considerations from a workshop and surveys. Physical and Engineering Sciences in Medicine, 45(1), 251-259. [More Information]
Ebert, M., Marcello, M., Kennedy, A., Haworth, A., Holloway, L., Greer, P., Dowling, J., Jameson, M., Roach, D., Joseph, D., et al (2022). In Regard to Shortall et al. International Journal of Radiation Oncology Biology Physics, 112(3), 831-833. [More Information]
Tadimalla, S., Wang, W., Haworth, A. (2022). Role of Functional MRI in Liver SBRT: Current Use and Future Directions. Cancers, 14(23). [More Information]
Reynolds, H., Tadimalla, S., Wang, Y., Montazerolghaem, M., Sun, Y., Williams, S., Mitchell, C., Finnegan, M., Murphy, D., Haworth, A. (2022). Semi-quantitative and quantitative dynamic contrast-enhanced (DCE) MRI parameters as prostate cancer imaging biomarkers for biologically targeted radiation therapy. Cancer Imaging, 22(1). [More Information]
Chlap, P., Min, H., Vandenberg, N., Dowling, J., Holloway, L., Haworth, A. (2021). A review of medical image data augmentation techniques for deep learning applications. Journal of Medical Imaging and Radiation Oncology, 65(5), 545-563. [More Information]
Wang, Y., Tadimalla, S., Hayden, A., Holloway, L., Haworth, A. (2021). Artificial intelligence and imaging biomarkers for prostate radiation therapy during and after treatment. Journal of Medical Imaging and Radiation Oncology, 65(5), 612-626. [More Information]
Thwaites, D., Moses, D., Haworth, A., Barton, M., Holloway, L. (2021). Artificial intelligence in medical imaging and radiation oncology: Opportunities and challenges. Journal of Medical Imaging and Radiation Oncology, 65(5), 481-485. [More Information]
Min, H., Dowling, J., Jameson, M., Cloak, K., Faustino, J., Sidhom, M., Martin, J., Ebert, M., Haworth, A., Chlap, P., Holloway, L., et al (2021). Automatic radiotherapy delineation quality assurance on prostate MRI with deep learning in a multicentre clinical trial. Physics in Medicine and Biology, 66(19), 195008. [More Information]
Her, E., Haworth, A., Sun, Y., Williams, S., Reynolds, H., Kennedy, A., Ebert, M. (2021). Biologically targeted radiation therapy: Incorporating patient-specific hypoxia data derived from quantitative magnetic resonance imaging. Cancers, 13(19), 4897. [More Information]
Di Re, A., Sun, Y., Sundaresan, P., Hau, E., Toh, J., Gee, H., Or, M., Haworth, A. (2021). MRI radiomics in the prediction of therapeutic response to neoadjuvant therapy for locoregionally advanced rectal cancer: a systematic review. Expert Review of Anticancer Therapy, 21(4), 425-449. [More Information]
Wang, Y., Tadimalla, S., Rai, R., Goodwin, J., Foster, S., Liney, G., Holloway, L., Haworth, A. (2021). Quantitative MRI: Defining repeatability, reproducibility and accuracy for prostate cancer imaging biomarker development. Magnetic resonance imaging, 77, 169-179. [More Information]
Her, E., Ebert, M., Kennedy, A., Reynolds, H., Sun, Y., Williams, S., Haworth, A. (2021). Standard versus hypofractionated intensity-modulated radiotherapy for prostate cancer: Assessing the impact on dose modulation and normal tissue effects when using patient-specific cancer biology. Physics in Medicine and Biology, 66(4), 45007. [More Information]
Vozzo, M., Poder, J., Yuen, J., Bucci, J., Haworth, A. (2021). Use of deformable image registration techniques to estimate dose to organs at risk following prostate external beam radiation therapy and high-dose-rate brachytherapy. Journal of Contemporary Brachytherapy, 13(1), 72-79. [More Information]
Kneebone, A., Fraser-Browne, C., Duchesne, G., Fisher, R., Frydenberg, M., Herschtal, A., Williams, S., Brown, C., Delprado, W., Haworth, A., Turner, S., Woo, H., et al (2020). Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial. The Lancet Oncology, 21(10), 1331-1340. [More Information]
Barber, J., Yuen, J., Jameson, M., Schmidt, L., Sykes, J., Gray, A., Hardcastle, N., Choong, C., Poder, J., Walker, A., Haworth, A., Thwaites, D., et al (2020). Deforming to Best Practice: Key considerations for deformable image registration in radiotherapy. Journal of Medical Radiation Sciences, 67(4), 318-332. [More Information]
Marcello, M., Denham, J., Kennedy, A., Haworth, A., Steigler, A., Greer, P., Holloway, L., Dowling, J., Jameson, M., Roach, D., et al (2020). Increased Dose to Organs in Urinary Tract Associates With Measures of Genitourinary Toxicity in Pooled Voxel-Based Analysis of 3 Randomized Phase III Trials. Frontiers in Oncology, 10, 1-20. [More Information]
Poder, J., Smith, R., Haworth, A. (2020). Low-dose-rate iodine-125 seed air kerma strength measurement intercomparison. Brachytherapy, 19(1), 119-125. [More Information]
Her, E., Haworth, A., Rowshanfarzad, P., Ebert, M. (2020). Progress towards patient-specific, spatially-continuous radiobiological dose prescription and planning in prostate cancer IMRT: An overview. Cancers, 12(4), 854. [More Information]
Joseph, D., Denham, J., Steigler, A., Lamb, D., Spry, N., Stanley, J., Shannon, T., Duchesne, G., Atkinson, C., Matthews, J., Haworth, A., et al (2020). Radiation Dose Escalation or Longer Androgen Suppression to Prevent Distant Progression in Men With Locally Advanced Prostate Cancer: 10-Year Data From the TROG 03.04 RADAR Trial. International Journal of Radiation Oncology Biology Physics, 106(4), 693-702. [More Information]
Marcello, M., Denham, J., Kennedy, A., Haworth, A., Steigler, A., Greer, P., Holloway, L., Dowling, J., Jameson, M., Roach, D., et al (2020). Reduced Dose Posterior to Prostate Correlates With Increased PSA Progression in Voxel-Based Analysis of 3 Randomized Phase 3 Trials. International Journal of Radiation Oncology Biology Physics, 108(5), 1304-1318. [More Information]
Marcello, M., Denham, J., Kennedy, A., Haworth, A., Steigler, A., Greer, P., Holloway, L., Dowling, J., Jameson, M., Roach, D., et al (2020). Relationships between rectal and perirectal doses and rectal bleeding or tenesmus in pooled voxel-based analysis of 3 randomised phase III trials. Radiotherapy and Oncology, 150, 281-292. [More Information]
Claridge Mackonis, E., Hardcastle, N., Haworth, A. (2020). Stereotactic ablative body radiation therapy (SABR) in NSW. Physical and Engineering Sciences in Medicine, 43(2), 641-650. [More Information]
Her, E., Haworth, A., Reynolds, H., Sun, Y., Kennedy, A., Panettieri, V., Bangert, M., Williams, S., Ebert, M. (2020). Voxel-level biological optimisation of prostate IMRT using patient-specific tumour location and clonogen density derived from mpMRI. Radiation Oncology, 15(1), 172. [More Information]
Haworth, A., Fielding, A., Marsh, S., Rowshanfarzad, P., Santos, A., Metcalfe, P., Franich, R. (2020). Will COVID-19 change the way we teach medical physics post pandemic? Physical and Engineering Sciences in Medicine, 43(3), 735-738. [More Information]
Sun, Y., Williams, S., Byrne, D., Keam, S., Reynolds, H., Mitchell, C., Wraith, D., Murphy, D., Haworth, A. (2019). Association analysis between quantitative MRI features and hypoxia-related genetic profiles in prostate cancer: A pilot study. British Journal of Radiology, 92(1104), 1-7. [More Information]
Sun, Y., Reynolds, H., Wraith, D., Williams, S., Finnegan, M., Mitchell, C., Murphy, D., Haworth, A. (2019). Automatic stratification of prostate tumour aggressiveness using multiparametric MRI: a horizontal comparison of texture features. Acta Oncologica, 58(8), 1118-1126. [More Information]
Cloak, K., Jameson, M., Paneghel, A., Wiltshire, K., Kneebone, A., Pearse, M., Sidhom, M., Tang, C., Fraser-Browne, C., Holloway, L., Haworth, A. (2019). Contour variation is a primary source of error when delivering post prostatectomy radiotherapy: Results of the Trans-Tasman Radiation Oncology Group 0803 Radiotherapy Adjuvant Versus Early Salvage (RAVES) benchmarking exercise. Journal of Medical Imaging and Radiation Oncology, 63(3), 390-398. [More Information]
Sun, Y., Reynolds, H., Parameswaran, B., Wraith, D., Finnegan, M., Williams, S., Haworth, A. (2019). Multiparametric MRI and radiomics in prostate cancer: a review. Australasian Physical and Engineering Sciences in Medicine, 42(1), 3-25. [More Information]
Reynolds, H., Williams, S., Jackson, P., Mitchell, C., Hofman, M., Hicks, R., Murphy, D., Haworth, A. (2019). Voxel-wise correlation of positron emission tomography/computed tomography with multiparametric magnetic resonance imaging and histology of the prostate using a sophisticated registration framework. BJU International, 123(6), 1020-1030. [More Information]
Bezak, E., Suchowerska, R., Claridge Mackonis, E., Pillen, H., Ralston, A., Haworth, A., Suchowerska, N. (2019). Women and men in the Australasian College of Physical Scientists and Engineers in Medicine: workforce survey. Australasian Physical and Engineering Sciences in Medicine, 42(1), 33-41. [More Information]
Smith, R., Hanlon, M., Panettieri, V., Millar, J., Matheson, B., Haworth, A., Franich, R. (2018). An integrated system for clinical treatment verification of HDR prostate brachytherapy combining source tracking with pretreatment imaging. Brachytherapy, 17(1), 111-121. [More Information]
Marcello, M., Ebert, M., Haworth, A., Steigler, A., Kennedy, A., Bulsara, M., Kearvell, R., Joseph, D., Denham, J. (2018). Association between measures of treatment quality and disease progression in prostate cancer radiotherapy: An exploratory analysis from the TROG 03.04 RADAR trial. Journal of Medical Imaging and Radiation Oncology, 62(2), 248-255. [More Information]
Marcello, M., Ebert, M., Haworth, A., Steigler, A., Kennedy, A., Joseph, D., Denham, J. (2018). Association between treatment planning and delivery factors and disease progression in prostate cancer radiotherapy: Results from the TROG 03.04 RADAR trial. Radiotherapy and Oncology, 126(2), 249-256. [More Information]
Her, E., Reynolds, H., Mears, C., Williams, S., Moorehouse, C., Millar, J., Ebert, M., Haworth, A. (2018). Radiobiological parameters in a tumour control probability model for prostate cancer LDR brachytherapy. Physics in Medicine and Biology, 63(13), 1-12. [More Information]
Liu, J., Dwyer, T., Marriott, K., Millar, J., Haworth, A. (2018). Understanding the Relationship between Interactive Optimisation and Visual Analytics in the Context of Prostate Brachytherapy. IEEE Transactions on Visualization and Computer Graphics, 24(1), 319-329. [More Information]
Sun, Y., Reynolds, H., Wraith, D., Williams, S., Finnegan, M., Mitchell, C., Murphy, D., Haworth, A. (2018). Voxel-wise prostate cell density prediction using multiparametric magnetic resonance imaging and machine learning. Acta Oncologica, 57(11), 1540-1546. [More Information]
Smith, R., Haworth, A., Panettieri, V., Millar, J., Franich, R. (2017). 3D catheter reconstruction in HDR prostate brachytherapy for pre-treatment verification using a flat panel detector. Physica Medica, 39, 121-131. [More Information]
Ma, Y., Vijande, J., Ballester, F., Carlsson Tedgren, A., Granero, D., Haworth, A., Mourtada, F., Fonseca, G., Zourari, K., Papagiannis, P., et al (2017). A generic TG-186 shielded applicator for commissioning model-based dose calculation algorithms for high-dose-rate 192Ir brachytherapy. Medical Physics, 44(11), 5961-5976. [More Information]
Antony, R., Herschtal, A., Todd, S., Phillips, C., Haworth, A. (2017). A pilot study on geometrical uncertainties for intra ocular cancers in radiotherapy. Australasian Physical and Engineering Sciences in Medicine, 40(2), 433-439. [More Information]
Hussein, M., Clementel, E., Eaton, D., Greer, P., Haworth, A., Ishikura, S., Kry, S., Lehmann, J., Lye, J., Monti, A., et al (2017). A virtual dosimetry audit – Towards transferability of gamma index analysis between clinical trial QA groups. Radiotherapy and Oncology, 125(3), 398-404. [More Information]
Haworth, A., Williams, S. (2017). Focal therapy for prostate cancer: the technical challenges. Journal of Contemporary Brachytherapy, 9(4), 383-389. [More Information]
Poder, J., Smith, R., Shelton, N., Whitaker, M., Butler, D., Haworth, A. (2017). High dose rate brachytherapy source measurement intercomparison. Australasian Physical and Engineering Sciences in Medicine, 40(2), 377-383. [More Information]
Sun, Y., Reynolds, H., Wraith, D., Williams, S., Finnegan, M., Mitchell, C., Murphy, D., Ebert, M., Haworth, A. (2017). Predicting prostate tumour location from multiparametric MRI using Gaussian kernel support vector machines: a preliminary study. Australasian Physical and Engineering Sciences in Medicine, 40(1), 39-49. [More Information]
Betts, J., Mears, C., Reynolds, H., Ebert, M., Haworth, A. (2017). Prostate cancer focal brachytherapy: Improving treatment plan robustness using a convolved dose rate model. Procedia Computer Science, 108C, 1522-1531. [More Information]
Smith, R., Haworth, A., Panettieri, V., Millar, J., Franich, R. (2016). A method for verification of treatment delivery in HDR prostate brachytherapy using a flat panel detector for both imaging and source tracking. Medical Physics, 43(5), 2435-2442. [More Information]
Haworth, A., Mears, C., Betts, J., Reynolds, H., Tack, G., Leo, K., Williams, S., Ebert, M. (2016). A radiobiology-based inverse treatment planning method for optimisation of permanent l-125 prostate implants in focal brachytherapy. Physics in Medicine and Biology, 61(1), 430-444. [More Information]
Haworth, A. (2016). Brachytherapy: a dying art or missed opportunity. Australasian Physical and Engineering Sciences in Medicine, 39(1), 5-9. [More Information]
Hardcastle, N., Oborn, B., Haworth, A. (2016). On the use of a convolution-superposition algorithm for plan checking in lung stereotactic body radiation therapy. Journal of Applied Clinical Medical Physics, 17(5), 99-110. [More Information]
Kron, T., Ungureanu, E., Antony, R., Hardcastle, N., Clements, N., Ukath, J., Fox, C., Lonski, P., Wanigaratne, D., Haworth, A. (2016). Patient specific quality control for Stereotactic Ablative Body Radiotherapy (SABR): It takes more than one phantom. Journal of Physics: Conference Series, 777(1), 1-4. [More Information]
Wilson, C., Waterhouse, D., Lane, S., Haworth, A., Stanley, J., Shannon, T., Joseph, D. (2016). Ten-year outcomes using low dose rate brachytherapy for localised prostate cancer: An update to the first Australian experience. Journal of Medical Imaging and Radiation Oncology, 60(4), 531-538. [More Information]
Duchesne, G., Haworth, A., Bone, E., Carter, H., Ebert, M., Gagliardi, F., Gibbs, A., Hornby, C., Martin, A., Sidhom, M., et al (2016). Testing the Assessment of New Radiation Oncology Technology and Treatments framework using the evaluation of post-prostatectomy radiotherapy techniques. Journal of Medical Imaging and Radiation Oncology, 60(1), 129-137. [More Information]
Haworth, A. (2016). Which patients benefit from post-implant CT dosimetry after real-time intraoperative planning for LDR prostate brachytherapy: Should intraoperatively planned patients be treated differently? Journal of Medical Imaging and Radiation Oncology, 60(2), 244-246. [More Information]
Ballester, F., Carlsson Tedgren, A., Domingo, G., Haworth, A., Mourtada, F., Fonseca, G., Zourari, K., Papagiannis, P., Rivard, M., et al (2015). A generic high-dose rate ¹⁹²Ir brachytherapy source for evaluation of model-based dose calculations beyond the TG-43 formalism. Medical Physics, 42(6), 3048-3062. [More Information]
Reynolds, H., Williams, S., Zhang, A., Chakravorty, R., Rawlinson, D., Ong, C., Esteva, M., Mitchell, C., Parameswaran, B., Finnegan, M., et al (2015). Development of a registration framework to validate MRI with histology for prostate focal therapy. Medical Physics, 42(12), 7078-7089. [More Information]
Brown, E., Cray, A., Haworth, A., Chander, S., Lin, R., Subramanian, B., Ng, M. (2015). Dose planning objectives in anal canal cancer IMRT: The TROG ANROTAT experience. Journal of Medical Radiation Sciences, 62(2), 99-107. [More Information]
Yahya, N., Ebert, M., Bulsara, M., Haworth, A., Kennedy, A., Joseph, D., Denham, J. (2015). Dosimetry, clinical factors and medication intake influencing urinary symptoms after prostate radiotherapy: An analysis of data from the RADAR prostate radiotherapy trial. Radiotherapy and Oncology, 116(1), 112-118. [More Information]
Weingant, M., Reynolds, H., Haworth, A., Mitchell, C., Williams, S., DiFranco, M. (2015). Ensemble prostate tumor classification in H&E whole slide imaging via stain normalization and cell density estimation. Lecture Notes in Computer Science (LNCS), 9352, 280-287. [More Information]
Ebert, M., Foo, K., Haworth, A., Gulliford, S., Kennedy, A., Joseph, D., Denham, J. (2015). Gastrointestinal Dose-Histogram Effects in the Context of Dose-Volume - Constrained Prostate Radiation Therapy: Analysis of Data From the RADAR Prostate Radiation Therapy Trial. International Journal of Radiation Oncology Biology Physics, 91(3), 595-603. [More Information]
Betts, J., Mears, C., Reynolds, H., Tack, G., Leo, K., Ebert, M., Haworth, A. (2015). Optimised robust treatment plans for prostate cancer focal brachytherapy. Procedia Computer Science, 51(1), 914-923. [More Information]
Trada, Y., Kneebone, A., Paneghel, A., Pearse, M., Sidhom, M., Tang, C., Wiltshire, K., Haworth, A., Fraser-Browne, C., Martin, J. (2015). Optimizing Radiation Therapy Quality Assurance in Clinical Trials: A TROG 08.03 RAVES Substudy. International Journal of Radiation Oncology Biology Physics, 93(5), 1045-1051. [More Information]
DiFranco, M., Reynolds, H., Mitchell, C., Williams, S., Allan, P., Haworth, A. (2015). Performance assessment of automated tissue characterization for prostate H&E stained histopathology. Progress in Biomedical Optics and Imaging, 9420, 94200M. [More Information]
Denham, J., Steigler, A., Joseph, D., Lamb, D., Spry, N., Duchesne, G., Atkinson, C., Matthews, J., Turner, S., Kenny, L., et al (2015). Radiation dose escalation or longer androgen suppression for locally advanced prostate cancer? Data from the TROG 03.04 RADAR trial. Radiotherapy and Oncology, 115(3), 301-307. [More Information]
Ebert, M., Bulsara, M., Haworth, A., Kearvell, R., Richardson, S., Kennedy, A., Spry, N., Bydder, S., Joseph, D., Denham, J. (2015). Technical quality assurance during the TROG 03.04 RADAR prostate radiotherapy trial: Are the results reflected in observed toxicity rates? Journal of Medical Imaging and Radiation Oncology, 59(1), 99-108. [More Information]
Taylor, M., Yeo, U., Supple, J., Keehan, S., Siva, S., Kron, T., Pham, D., Haworth, A., Franich, R. (2015). The Importance of Quasi-4D Path-Integrated Dose Accumulation for More Accurate Risk Estimation in Stereotactic Liver Radiotherapy. Technology in Cancer Research and Treatment, 15(3), 428-436. [More Information]
Duchesne, G., Grand, M., Kron, T., Haworth, A., Corry, J., Jackson, M., Ng, M., Besuijen, D., Carter, H., Martin, A., Schofield, D., Gebski, V., et al (2015). Trans Tasman Radiation Oncology Group: Development of the Assessment of New Radiation Oncology Technology and Treatments (ANROTAT) Framework. Journal of Medical Imaging and Radiation Oncology, 59(3), 363-370. [More Information]
Carter, H., Martin, A., Schofield, D., Duchesne, G., Haworth, A., Hornby, C., Sidhom, M., Jackson, M. (2014). A decision model to estimate the cost-effectiveness of intensity modulated radiation therapy (IMRT) compared to three dimensional conformal radiation therapy (3DCRT) in patients receiving radiotherapy to the prostate bed. Radiotherapy and Oncology, 112(2), 187-193. [More Information]
Pearse, M., Fraser-Browne, C., Davis, I., Duchesne, G., Fisher, R., Frydenberg, M., Haworth, A., Jose, C., Joseph, D., Woo, H., et al (2014). A Phase III trial to investigate the timing of radiotherapy for prostate cancer with high-risk features: background and rationale of the Radiotherapy - Adjuvant Versus Early Salvage (RAVES) trial. BJU International, 113(Suppl 2), 7-12. [More Information]
Reynolds, H., Williams, S., Zhang, A., Ong, C., Rawlinson, D., Chakravorty, R., Mitchell, C., Haworth, A. (2014). Cell density in prostate histopathology images as a measure of tumor distribution. Progress in Biomedical Optics and Imaging, 9041, 90410S. [More Information]
Ebert, M., Foo, K., Haworth, A., Gulliford, S., Kearvall, R., Kennedy, A., Richardson, S., Krawiec, M., Stewart, N., Joseph, D., et al (2014). Derivation and representation of dose-volume response from large clinical trial data sets: An example from the RADAR prostate radiotherapy trial. Journal of Physics: Conference Series, 489(1), 1-5. [More Information]
Melidis, C., Bosch, W., Izewska, J., Fidarova, E., Zubizarreta, E., Ulin, K., Ishikura, S., Followill, D., Galvin, J., Haworth, A., et al (2014). Global Harmonization of Quality Assurance Naming Conventions in Radiation Therapy Clinical Trials. International Journal of Radiation Oncology Biology Physics, 90(5), 1242-1249. [More Information]
Yahya, N., Ebert, M., Bulsara, M., Haworth, A., Kearvell, R., Foo, K., Kennedy, A., Richardson, S., Krawiec, M., Joseph, D., et al (2014). Impact of treatment planning and delivery factors on gastrointestinal toxicity: An analysis of data from the RADAR prostate radiotherapy trial. Radiation Oncology, 9(1), 1-10. [More Information]
Haworth, A., Paneghel, A., Bressel, M., Herschtal, A., Pham, D., Tai, K., Oates, R., Gawthrop, J., Cray, A., Foroudi, F. (2014). Prostate Bed Radiation Therapy: The Utility of Ultrasound Volumetric Imaging of the Bladder. Clinical Oncology, 26(12), 789-796. [More Information]
Ebert, M., Gulliford, S., Buettner, F., Foo, K., Haworth, A., Kennedy, A., Joseph, D., Denham, J. (2014). Two non-parametric methods for derivation of constraints from radiotherapy dose-histogram data. Physics in Medicine and Biology, 59(13), N101-N111. [More Information]
Dempsey, C., Smith, R., Nyathi, T., Ceylan, A., Howard, L., Patel, V., Das, R., Haworth, A. (2013). ACPSEM brachytherapy working group recommendations for quality assurance in brachytherapy. Australasian Physical and Engineering Sciences in Medicine, 36(4), 387-396. [More Information]
Haworth, A., Wilfert, L., Butler, D., Ebert, M., Todd, S., Bucci, J., Duchesne, G., Joseph, D., Kron, T. (2013). Australasian brachytherapy audit: Results of the 'end-to-end' dosimetry pilot study. Journal of Medical Imaging and Radiation Oncology, 57(4), 490-498. [More Information]
Haworth, A., Butler, D., Wilfert, L., Ebert, M., Todd, S., Hayton, A., Kron, T. (2013). Comparison of TLD calibration methods for 192Ir dosimetry. Journal of Applied Clinical Medical Physics, 14(1), 258-272. [More Information]
Ibbott, G., Haworth, A., Followill, D. (2013). Quality assurance for clinical trials. Frontiers in Oncology, 3, 1-11. [More Information]
Kearvell, R., Haworth, A., Ebert, M., Murray, J., Hooton, B., Richardson, S., Joseph, D., Lamb, D., Spry, N., Duchesne, G., et al (2013). Quality improvements in prostate radiotherapy: Outcomes and impact of comprehensive quality assurance during the TROG 03.04 'RADAR' trial. Journal of Medical Imaging and Radiation Oncology, 57(2), 247-257. [More Information]
Smith, R., Taylor, M., McDermott, L., Haworth, A., Millar, J., Franich, R. (2013). Source position verification and dosimetry in HDR brachytherapy using an EPID. Medical Physics, 40(11), 1-12. [More Information]
Papagiannis, P., Ballester, F., 60025709, C., Haworth, A., Ibbott, G., Mourtada, F., Rivard, M., Siebert, F., Sloboda, R., Thomson, R., et al (2013). SU‐E‐T‐509: DICOM Test Case Plans for Model‐Based Dose Calculations Methods in Brachytherapy. Medical Physics, 40(6), 322. [More Information]
Foo, K., Ebert, M., Carolan, M., Haworth, A., Bulsara, M., Joseph, D., Denham, J. (2013). TU‐G‐108‐06: Anatomical Localization of Late Rectal Toxicity Predictors in Prostate Radiotherapy. Medical Physics, 40(6), 454. [More Information]
Haworth, A., Williams, S., Reynolds, H., Waterhouse, D., Duchesne, G., Bucci, J., Joseph, D., Bydder, S., Ebert, M. (2013). Validation of a radiobiological model for low-dose-rate prostate boost focal therapy treatment planning. Brachytherapy, 12(6), 628-636. [More Information]
Foroudi, F., Wilson, L., Bressel, M., Haworth, A., Hornby, C., Pham, D., Cramb, J., Gill, S., Tai, K., Kron, T. (2012). A dosimetric comparison of 3D conformal vs intensity modulated vs volumetric arc radiation therapy for muscle invasive bladder cancer. Radiation Oncology, 7(1), 111. [More Information]
Senthi, S., Gill, S., Haworth, A., Kron, T., Cramb, J., Rolfo, A., Thomas, J., Duchesne, G., Hamilton, C., et al (2012). Benchmarking dosimetric quality assessment of prostate intensity-modulated radiotherapy. International Journal of Radiation Oncology Biology Physics, 82(2), 998-1005. [More Information]
Nguyen, B., Hornby, C., Kron, T., Cramb, J., Rolfo, A., Pham, D., Haworth, A., Tai, K., Foroudi, F. (2012). Optimising the dosimetric quality and efficiency of post-prostatectomy radiotherapy: A planning study comparing the performance of volumetric-modulated arc therapy (VMAT) with an optimised seven-field intensity-modulated radiotherapy (IMRT) technique. Journal of Medical Imaging and Radiation Oncology, 56(2), 211-219. [More Information]
Mak, D., Gill, S., Paul, R., Stillie, A., Haworth, A., Kron, T., Cramb, J., Knight, K., Thomas, J., Duchesne, G., et al (2012). Seminal vesicle interfraction displacement and margins in image guided radiotherapy for prostate cancer. Radiation Oncology, 7(1), 1-9. [More Information]
Ebert, M., McDermott, L., Haworth, A., van der Wath, E., Hooton, B. (2012). Tools to analyse and display variations in anatomical delineation. Australasian Physical and Engineering Sciences in Medicine, 35(2), 159-164. [More Information]
Roozen, K., Kron, T., Haworth, A., Franich, R. (2011). Evaluation of EBT radiochromic film using a multiple exposure technique. Australasian Physical and Engineering Sciences in Medicine, 34(2), 281-289. [More Information]
Fox, C., Kron, T., Leahy, M., Duchesne, G., Williams, S., Tai, K., Haworth, A., Herschtal, A., Foroudi, F. (2011). Interfraction patient motion and implant displacement in prostate high dose rate brachytherapy. Medical Physics, 38(11), 5838-5843. [More Information]
Hayton, A., Haworth, A., Waterhouse, D., Todd, S., Pillainayagam, J. (2011). Lack of backscatter factor measurements in HDR applications with MOSkins. Australasian Physical and Engineering Sciences in Medicine, 34(4), 545-552. [More Information]
Foroudi, F., Wong, J., Kron, T., Rolfo, A., Haworth, A., Roxby, P., Thomas, J., Herschtal, A., Pham, D., Williams, S., et al (2011). Online adaptive radiotherapy for muscle-invasive bladder cancer: Results of a pilot study. International Journal of Radiation Oncology Biology Physics, 81(3), 765-771. [More Information]

show 107 more

Conferences

Haworth, A., Sun, Y., Ebert, M., Reynolds, H., Betts, J., Wraith, D., Mitchell, C., Murphy, D., Parameswaran, B., Williams, S. (2019). Use of contemporary prostate brachytherapy approaches in clinical trials. Mini-Micro and Nano Dosimetry (MMND 2018), Mooloolaba: Institute of Physics Publishing. [More Information]
Ghasab, M., Paplinski, A., Betts, J., Reynolds, H., Haworth, A. (2017). Automatic 3D modelling for prostate cancer brachytherapy. 2017 IEEE International Conference on Image Processing (ICIP 2017), China: Institute of Electrical and Electronics Engineers (IEEE). [More Information]

By Year

Expand all

2024

Wigg, A., Tibballs, J., Woodman, R., Stuart, K., Le, H., Roberts, S., Olynyk, J., Strasser, S., Wallace, M., Martin, J., Haworth, A., et al (2024). A randomised controlled trial of Standard Of Care versus RadioAblaTion in Early Stage HepatoCellular Carcinoma (SOCRATES HCC). BMC Cancer, 24(1). [More Information]
Le Bao, V., Cloak, K., Sidhom, M., Kneebone, A., Holloway, L., Haworth, A., Dowling, J., Walker, A., Arumugam, S., Jameson, M., et al (2024). Evaluating the relationship between contouring variability and modelled treatment outcome for prostate bed radiotherapy. Physics in Medicine and Biology, 69(8), 085008. [More Information]
Claridge Mackonis, E., Haworth, A., Stensmyr, R., Poldy, R., White, P., Moutrie, Z., Gorjiara, T., Seymour, E., Erven, T., Hardcastle, N. (2024). Improving motion management in radiation therapy: findings from a workshop and survey in Australia and New Zealand. Physical and Engineering Sciences in Medicine. [More Information]
Phillips, C., Pinkham, M., Moore, A., Sia, J., Jeffree, R., Khasraw, M., Kam, A., Bressel, M., Haworth, A. (2024). Local hero: A phase II study of local therapy only (stereotactic radiosurgery and / or surgery) for treatment of up to five brain metastases from HER2+ breast cancer. (TROG study 16.02). Breast, 74, 103675. [More Information]
Dutta, A., Chan, J., Haworth, A., Dubowitz, D., Kneebone, A., Reynolds, H. (2024). Robustness of magnetic resonance imaging and positron emission tomography radiomic features in prostate cancer: Impact on recurrence prediction after radiation therapy. Physics And Imaging In Radiation Oncology, 29. [More Information]
Zhao, Y., Haworth, A., Reynolds, H., Williams, S., Finnegan, R., Rowshanfarzad, P., Ebert, M. (2024). Towards optimal heterogeneous prostate radiotherapy dose prescriptions based on patient-specific or population-based biological features. Medical Physics. [More Information]
Chlap, P., Tran, P., Kron, T., Sidhom, M., Wiltshire, K., Keats, S., Kneebone, A., Haworth, A., Ebert, M., Vinod, S., Holloway, L., et al (2024). Uncertainty estimation using a 3D probabilistic U-Net for segmentation with small radiotherapy clinical trial datasets. Computerized Medical Imaging and Graphics, 116, 102403. [More Information]

show 4 more

2023

Claridge Mackonis, E., Hardcastle, N., Haworth, A. (2023). A survey of compliance with stereotactic ablative body radiotherapy quality recommendations. Journal of Medical Imaging and Radiation Oncology. [More Information]
Beaulieu, L., Ballester, F., Granero, D., Tedgren, Å., Haworth, A., Lowenstein, J., Ma, Y., Mourtada, F., Papagiannis, P., Rivard, M., et al (2023). AAPM WGDCAB Report 372: A joint AAPM, ESTRO, ABG, and ABS report on commissioning of model-based dose calculation algorithms in brachytherapy. Medical Physics, 50(8), e946-e960. [More Information]
Min, H., Dowling, J., Jameson, M., Cloak, K., Faustino, J., Sidhom, M., Martin, J., Cardoso, M., Ebert, M., Haworth, A., Holloway, L., et al (2023). Clinical target volume delineation quality assurance for MRI-guided prostate radiotherapy using deep learning with uncertainty estimation. Radiotherapy and Oncology, 186. [More Information]
Chan, T., Haworth, A., Wang, A., Osanlouy, M., Williams, S., Mitchell, C., Hofman, M., Hicks, R., Murphy, D., Reynolds, H. (2023). Detecting localised prostate cancer using radiomic features in PSMA PET and multiparametric MRI for biologically targeted radiation therapy. EJNMMI Research, 13(34), 1-14.
Zhao, Y., Haworth, A., Rowshanfarzad, P., Ebert, M. (2023). Focal Boost in Prostate Cancer Radiotherapy: A Review of Planning Studies and Clinical Trials. Cancers, 15(19). [More Information]
Davoudi, F., Batra, J., Moradi, A., Becker, T., Lock, J., Abbey, B., Fontanarosa, D., Haworth, A., Clements, J., Ecker, R. (2023). Genomic and Phenotypic Biomarkers for Precision Medicine Guidance in Advanced Prostate Cancer. Current Treatment Options in Oncology, 24(10), 1451-1471. [More Information]
Zhao, Y., Haworth, A., Reynolds, H., Her, E., Sun, Y., Finnegan, R., Rowshanfarzad, P., Ebert, M. (2023). Patient-specific voxel-level dose prescription for prostate cancer radiotherapy considering tumor cell density and grade distribution. Medical Physics. [More Information]
Poder, J., Rivard, M., Howie, A., 60025709, C., Haworth, A. (2023). Risk and Quality in Brachytherapy From a Technical Perspective. Clinical Oncology. [More Information]
Thwaites, D., Prokopovich, D., Garrett, R., Haworth, A., Rosenfeld, A., Ahern, V. (2023). The rationale for a carbon ion radiation therapy facility in Australia. Journal of Medical Radiation Sciences. [More Information]
Montazerolghaem, M., Sun, Y., Sasso, G., Haworth, A. (2023). U-Net Architecture for Prostate Segmentation: The Impact of Loss Function on System Performance. Bioengineering, 10(412), 1-19. [More Information]

show 7 more

2022

Claridge Mackonis, E., Sykes, J., Hardcastle, N., Espinoza, A., Brown, A., Perez, G., Evans, B., Sheehan, H., Haworth, A. (2022). A comparison of in-house and shared RapidPlan models for prostate radiation therapy planning. Physical and Engineering Sciences in Medicine, 45(4), 1029-1041. [More Information]
Finnegan, R., Reynolds, H., Ebert, M., Sun, Y., Holloway, L., Sykes, J., Dowling, J., Mitchell, C., Williams, S., Murphy, D., Haworth, A. (2022). A statistical, voxelised model of prostate cancer for biologically optimised radiotherapy. Physics And Imaging In Radiation Oncology, 21, 136-145. [More Information]
Pudsey, L., Haworth, A., White, P., Moutrie, Z., Jonker, B., Foote, M., Poder, J. (2022). Current status of intra-cranial stereotactic radiotherapy and stereotactic radiosurgery in Australia and New Zealand: key considerations from a workshop and surveys. Physical and Engineering Sciences in Medicine, 45(1), 251-259. [More Information]
Ebert, M., Marcello, M., Kennedy, A., Haworth, A., Holloway, L., Greer, P., Dowling, J., Jameson, M., Roach, D., Joseph, D., et al (2022). In Regard to Shortall et al. International Journal of Radiation Oncology Biology Physics, 112(3), 831-833. [More Information]
Tadimalla, S., Wang, W., Haworth, A. (2022). Role of Functional MRI in Liver SBRT: Current Use and Future Directions. Cancers, 14(23). [More Information]
Reynolds, H., Tadimalla, S., Wang, Y., Montazerolghaem, M., Sun, Y., Williams, S., Mitchell, C., Finnegan, M., Murphy, D., Haworth, A. (2022). Semi-quantitative and quantitative dynamic contrast-enhanced (DCE) MRI parameters as prostate cancer imaging biomarkers for biologically targeted radiation therapy. Cancer Imaging, 22(1). [More Information]

show 3 more

2021

Chlap, P., Min, H., Vandenberg, N., Dowling, J., Holloway, L., Haworth, A. (2021). A review of medical image data augmentation techniques for deep learning applications. Journal of Medical Imaging and Radiation Oncology, 65(5), 545-563. [More Information]
Wang, Y., Tadimalla, S., Hayden, A., Holloway, L., Haworth, A. (2021). Artificial intelligence and imaging biomarkers for prostate radiation therapy during and after treatment. Journal of Medical Imaging and Radiation Oncology, 65(5), 612-626. [More Information]
Thwaites, D., Moses, D., Haworth, A., Barton, M., Holloway, L. (2021). Artificial intelligence in medical imaging and radiation oncology: Opportunities and challenges. Journal of Medical Imaging and Radiation Oncology, 65(5), 481-485. [More Information]
Min, H., Dowling, J., Jameson, M., Cloak, K., Faustino, J., Sidhom, M., Martin, J., Ebert, M., Haworth, A., Chlap, P., Holloway, L., et al (2021). Automatic radiotherapy delineation quality assurance on prostate MRI with deep learning in a multicentre clinical trial. Physics in Medicine and Biology, 66(19), 195008. [More Information]
Her, E., Haworth, A., Sun, Y., Williams, S., Reynolds, H., Kennedy, A., Ebert, M. (2021). Biologically targeted radiation therapy: Incorporating patient-specific hypoxia data derived from quantitative magnetic resonance imaging. Cancers, 13(19), 4897. [More Information]
Di Re, A., Sun, Y., Sundaresan, P., Hau, E., Toh, J., Gee, H., Or, M., Haworth, A. (2021). MRI radiomics in the prediction of therapeutic response to neoadjuvant therapy for locoregionally advanced rectal cancer: a systematic review. Expert Review of Anticancer Therapy, 21(4), 425-449. [More Information]
Wang, Y., Tadimalla, S., Rai, R., Goodwin, J., Foster, S., Liney, G., Holloway, L., Haworth, A. (2021). Quantitative MRI: Defining repeatability, reproducibility and accuracy for prostate cancer imaging biomarker development. Magnetic resonance imaging, 77, 169-179. [More Information]
Her, E., Ebert, M., Kennedy, A., Reynolds, H., Sun, Y., Williams, S., Haworth, A. (2021). Standard versus hypofractionated intensity-modulated radiotherapy for prostate cancer: Assessing the impact on dose modulation and normal tissue effects when using patient-specific cancer biology. Physics in Medicine and Biology, 66(4), 45007. [More Information]
Vozzo, M., Poder, J., Yuen, J., Bucci, J., Haworth, A. (2021). Use of deformable image registration techniques to estimate dose to organs at risk following prostate external beam radiation therapy and high-dose-rate brachytherapy. Journal of Contemporary Brachytherapy, 13(1), 72-79. [More Information]

show 6 more

2020

Kneebone, A., Fraser-Browne, C., Duchesne, G., Fisher, R., Frydenberg, M., Herschtal, A., Williams, S., Brown, C., Delprado, W., Haworth, A., Turner, S., Woo, H., et al (2020). Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial. The Lancet Oncology, 21(10), 1331-1340. [More Information]
Barber, J., Yuen, J., Jameson, M., Schmidt, L., Sykes, J., Gray, A., Hardcastle, N., Choong, C., Poder, J., Walker, A., Haworth, A., Thwaites, D., et al (2020). Deforming to Best Practice: Key considerations for deformable image registration in radiotherapy. Journal of Medical Radiation Sciences, 67(4), 318-332. [More Information]
Marcello, M., Denham, J., Kennedy, A., Haworth, A., Steigler, A., Greer, P., Holloway, L., Dowling, J., Jameson, M., Roach, D., et al (2020). Increased Dose to Organs in Urinary Tract Associates With Measures of Genitourinary Toxicity in Pooled Voxel-Based Analysis of 3 Randomized Phase III Trials. Frontiers in Oncology, 10, 1-20. [More Information]
Poder, J., Smith, R., Haworth, A. (2020). Low-dose-rate iodine-125 seed air kerma strength measurement intercomparison. Brachytherapy, 19(1), 119-125. [More Information]
Her, E., Haworth, A., Rowshanfarzad, P., Ebert, M. (2020). Progress towards patient-specific, spatially-continuous radiobiological dose prescription and planning in prostate cancer IMRT: An overview. Cancers, 12(4), 854. [More Information]
Joseph, D., Denham, J., Steigler, A., Lamb, D., Spry, N., Stanley, J., Shannon, T., Duchesne, G., Atkinson, C., Matthews, J., Haworth, A., et al (2020). Radiation Dose Escalation or Longer Androgen Suppression to Prevent Distant Progression in Men With Locally Advanced Prostate Cancer: 10-Year Data From the TROG 03.04 RADAR Trial. International Journal of Radiation Oncology Biology Physics, 106(4), 693-702. [More Information]
Marcello, M., Denham, J., Kennedy, A., Haworth, A., Steigler, A., Greer, P., Holloway, L., Dowling, J., Jameson, M., Roach, D., et al (2020). Reduced Dose Posterior to Prostate Correlates With Increased PSA Progression in Voxel-Based Analysis of 3 Randomized Phase 3 Trials. International Journal of Radiation Oncology Biology Physics, 108(5), 1304-1318. [More Information]
Marcello, M., Denham, J., Kennedy, A., Haworth, A., Steigler, A., Greer, P., Holloway, L., Dowling, J., Jameson, M., Roach, D., et al (2020). Relationships between rectal and perirectal doses and rectal bleeding or tenesmus in pooled voxel-based analysis of 3 randomised phase III trials. Radiotherapy and Oncology, 150, 281-292. [More Information]
Claridge Mackonis, E., Hardcastle, N., Haworth, A. (2020). Stereotactic ablative body radiation therapy (SABR) in NSW. Physical and Engineering Sciences in Medicine, 43(2), 641-650. [More Information]
Her, E., Haworth, A., Reynolds, H., Sun, Y., Kennedy, A., Panettieri, V., Bangert, M., Williams, S., Ebert, M. (2020). Voxel-level biological optimisation of prostate IMRT using patient-specific tumour location and clonogen density derived from mpMRI. Radiation Oncology, 15(1), 172. [More Information]
Haworth, A., Fielding, A., Marsh, S., Rowshanfarzad, P., Santos, A., Metcalfe, P., Franich, R. (2020). Will COVID-19 change the way we teach medical physics post pandemic? Physical and Engineering Sciences in Medicine, 43(3), 735-738. [More Information]

show 8 more

2019

Sun, Y., Williams, S., Byrne, D., Keam, S., Reynolds, H., Mitchell, C., Wraith, D., Murphy, D., Haworth, A. (2019). Association analysis between quantitative MRI features and hypoxia-related genetic profiles in prostate cancer: A pilot study. British Journal of Radiology, 92(1104), 1-7. [More Information]
Sun, Y., Reynolds, H., Wraith, D., Williams, S., Finnegan, M., Mitchell, C., Murphy, D., Haworth, A. (2019). Automatic stratification of prostate tumour aggressiveness using multiparametric MRI: a horizontal comparison of texture features. Acta Oncologica, 58(8), 1118-1126. [More Information]
Cloak, K., Jameson, M., Paneghel, A., Wiltshire, K., Kneebone, A., Pearse, M., Sidhom, M., Tang, C., Fraser-Browne, C., Holloway, L., Haworth, A. (2019). Contour variation is a primary source of error when delivering post prostatectomy radiotherapy: Results of the Trans-Tasman Radiation Oncology Group 0803 Radiotherapy Adjuvant Versus Early Salvage (RAVES) benchmarking exercise. Journal of Medical Imaging and Radiation Oncology, 63(3), 390-398. [More Information]
Sun, Y., Reynolds, H., Parameswaran, B., Wraith, D., Finnegan, M., Williams, S., Haworth, A. (2019). Multiparametric MRI and radiomics in prostate cancer: a review. Australasian Physical and Engineering Sciences in Medicine, 42(1), 3-25. [More Information]
Haworth, A., Sun, Y., Ebert, M., Reynolds, H., Betts, J., Wraith, D., Mitchell, C., Murphy, D., Parameswaran, B., Williams, S. (2019). Use of contemporary prostate brachytherapy approaches in clinical trials. Mini-Micro and Nano Dosimetry (MMND 2018), Mooloolaba: Institute of Physics Publishing. [More Information]
Reynolds, H., Williams, S., Jackson, P., Mitchell, C., Hofman, M., Hicks, R., Murphy, D., Haworth, A. (2019). Voxel-wise correlation of positron emission tomography/computed tomography with multiparametric magnetic resonance imaging and histology of the prostate using a sophisticated registration framework. BJU International, 123(6), 1020-1030. [More Information]
Bezak, E., Suchowerska, R., Claridge Mackonis, E., Pillen, H., Ralston, A., Haworth, A., Suchowerska, N. (2019). Women and men in the Australasian College of Physical Scientists and Engineers in Medicine: workforce survey. Australasian Physical and Engineering Sciences in Medicine, 42(1), 33-41. [More Information]

show 4 more

2018

Smith, R., Hanlon, M., Panettieri, V., Millar, J., Matheson, B., Haworth, A., Franich, R. (2018). An integrated system for clinical treatment verification of HDR prostate brachytherapy combining source tracking with pretreatment imaging. Brachytherapy, 17(1), 111-121. [More Information]
Marcello, M., Ebert, M., Haworth, A., Steigler, A., Kennedy, A., Bulsara, M., Kearvell, R., Joseph, D., Denham, J. (2018). Association between measures of treatment quality and disease progression in prostate cancer radiotherapy: An exploratory analysis from the TROG 03.04 RADAR trial. Journal of Medical Imaging and Radiation Oncology, 62(2), 248-255. [More Information]
Marcello, M., Ebert, M., Haworth, A., Steigler, A., Kennedy, A., Joseph, D., Denham, J. (2018). Association between treatment planning and delivery factors and disease progression in prostate cancer radiotherapy: Results from the TROG 03.04 RADAR trial. Radiotherapy and Oncology, 126(2), 249-256. [More Information]
Her, E., Reynolds, H., Mears, C., Williams, S., Moorehouse, C., Millar, J., Ebert, M., Haworth, A. (2018). Radiobiological parameters in a tumour control probability model for prostate cancer LDR brachytherapy. Physics in Medicine and Biology, 63(13), 1-12. [More Information]
Liu, J., Dwyer, T., Marriott, K., Millar, J., Haworth, A. (2018). Understanding the Relationship between Interactive Optimisation and Visual Analytics in the Context of Prostate Brachytherapy. IEEE Transactions on Visualization and Computer Graphics, 24(1), 319-329. [More Information]
Sun, Y., Reynolds, H., Wraith, D., Williams, S., Finnegan, M., Mitchell, C., Murphy, D., Haworth, A. (2018). Voxel-wise prostate cell density prediction using multiparametric magnetic resonance imaging and machine learning. Acta Oncologica, 57(11), 1540-1546. [More Information]

show 3 more

2017

Smith, R., Haworth, A., Panettieri, V., Millar, J., Franich, R. (2017). 3D catheter reconstruction in HDR prostate brachytherapy for pre-treatment verification using a flat panel detector. Physica Medica, 39, 121-131. [More Information]
Ma, Y., Vijande, J., Ballester, F., Carlsson Tedgren, A., Granero, D., Haworth, A., Mourtada, F., Fonseca, G., Zourari, K., Papagiannis, P., et al (2017). A generic TG-186 shielded applicator for commissioning model-based dose calculation algorithms for high-dose-rate 192Ir brachytherapy. Medical Physics, 44(11), 5961-5976. [More Information]
Antony, R., Herschtal, A., Todd, S., Phillips, C., Haworth, A. (2017). A pilot study on geometrical uncertainties for intra ocular cancers in radiotherapy. Australasian Physical and Engineering Sciences in Medicine, 40(2), 433-439. [More Information]
Hussein, M., Clementel, E., Eaton, D., Greer, P., Haworth, A., Ishikura, S., Kry, S., Lehmann, J., Lye, J., Monti, A., et al (2017). A virtual dosimetry audit – Towards transferability of gamma index analysis between clinical trial QA groups. Radiotherapy and Oncology, 125(3), 398-404. [More Information]
Ghasab, M., Paplinski, A., Betts, J., Reynolds, H., Haworth, A. (2017). Automatic 3D modelling for prostate cancer brachytherapy. 2017 IEEE International Conference on Image Processing (ICIP 2017), China: Institute of Electrical and Electronics Engineers (IEEE). [More Information]
Haworth, A., Williams, S. (2017). Focal therapy for prostate cancer: the technical challenges. Journal of Contemporary Brachytherapy, 9(4), 383-389. [More Information]
Poder, J., Smith, R., Shelton, N., Whitaker, M., Butler, D., Haworth, A. (2017). High dose rate brachytherapy source measurement intercomparison. Australasian Physical and Engineering Sciences in Medicine, 40(2), 377-383. [More Information]
Sun, Y., Reynolds, H., Wraith, D., Williams, S., Finnegan, M., Mitchell, C., Murphy, D., Ebert, M., Haworth, A. (2017). Predicting prostate tumour location from multiparametric MRI using Gaussian kernel support vector machines: a preliminary study. Australasian Physical and Engineering Sciences in Medicine, 40(1), 39-49. [More Information]
Betts, J., Mears, C., Reynolds, H., Ebert, M., Haworth, A. (2017). Prostate cancer focal brachytherapy: Improving treatment plan robustness using a convolved dose rate model. Procedia Computer Science, 108C, 1522-1531. [More Information]

show 6 more

2016

Smith, R., Haworth, A., Panettieri, V., Millar, J., Franich, R. (2016). A method for verification of treatment delivery in HDR prostate brachytherapy using a flat panel detector for both imaging and source tracking. Medical Physics, 43(5), 2435-2442. [More Information]
Haworth, A., Mears, C., Betts, J., Reynolds, H., Tack, G., Leo, K., Williams, S., Ebert, M. (2016). A radiobiology-based inverse treatment planning method for optimisation of permanent l-125 prostate implants in focal brachytherapy. Physics in Medicine and Biology, 61(1), 430-444. [More Information]
Haworth, A. (2016). Brachytherapy: a dying art or missed opportunity. Australasian Physical and Engineering Sciences in Medicine, 39(1), 5-9. [More Information]
Hardcastle, N., Oborn, B., Haworth, A. (2016). On the use of a convolution-superposition algorithm for plan checking in lung stereotactic body radiation therapy. Journal of Applied Clinical Medical Physics, 17(5), 99-110. [More Information]
Kron, T., Ungureanu, E., Antony, R., Hardcastle, N., Clements, N., Ukath, J., Fox, C., Lonski, P., Wanigaratne, D., Haworth, A. (2016). Patient specific quality control for Stereotactic Ablative Body Radiotherapy (SABR): It takes more than one phantom. Journal of Physics: Conference Series, 777(1), 1-4. [More Information]
Wilson, C., Waterhouse, D., Lane, S., Haworth, A., Stanley, J., Shannon, T., Joseph, D. (2016). Ten-year outcomes using low dose rate brachytherapy for localised prostate cancer: An update to the first Australian experience. Journal of Medical Imaging and Radiation Oncology, 60(4), 531-538. [More Information]
Duchesne, G., Haworth, A., Bone, E., Carter, H., Ebert, M., Gagliardi, F., Gibbs, A., Hornby, C., Martin, A., Sidhom, M., et al (2016). Testing the Assessment of New Radiation Oncology Technology and Treatments framework using the evaluation of post-prostatectomy radiotherapy techniques. Journal of Medical Imaging and Radiation Oncology, 60(1), 129-137. [More Information]
Haworth, A. (2016). Which patients benefit from post-implant CT dosimetry after real-time intraoperative planning for LDR prostate brachytherapy: Should intraoperatively planned patients be treated differently? Journal of Medical Imaging and Radiation Oncology, 60(2), 244-246. [More Information]

show 5 more

2015

Ballester, F., Carlsson Tedgren, A., Domingo, G., Haworth, A., Mourtada, F., Fonseca, G., Zourari, K., Papagiannis, P., Rivard, M., et al (2015). A generic high-dose rate ¹⁹²Ir brachytherapy source for evaluation of model-based dose calculations beyond the TG-43 formalism. Medical Physics, 42(6), 3048-3062. [More Information]
Reynolds, H., Williams, S., Zhang, A., Chakravorty, R., Rawlinson, D., Ong, C., Esteva, M., Mitchell, C., Parameswaran, B., Finnegan, M., et al (2015). Development of a registration framework to validate MRI with histology for prostate focal therapy. Medical Physics, 42(12), 7078-7089. [More Information]
Brown, E., Cray, A., Haworth, A., Chander, S., Lin, R., Subramanian, B., Ng, M. (2015). Dose planning objectives in anal canal cancer IMRT: The TROG ANROTAT experience. Journal of Medical Radiation Sciences, 62(2), 99-107. [More Information]
Yahya, N., Ebert, M., Bulsara, M., Haworth, A., Kennedy, A., Joseph, D., Denham, J. (2015). Dosimetry, clinical factors and medication intake influencing urinary symptoms after prostate radiotherapy: An analysis of data from the RADAR prostate radiotherapy trial. Radiotherapy and Oncology, 116(1), 112-118. [More Information]
Weingant, M., Reynolds, H., Haworth, A., Mitchell, C., Williams, S., DiFranco, M. (2015). Ensemble prostate tumor classification in H&E whole slide imaging via stain normalization and cell density estimation. Lecture Notes in Computer Science (LNCS), 9352, 280-287. [More Information]
Ebert, M., Foo, K., Haworth, A., Gulliford, S., Kennedy, A., Joseph, D., Denham, J. (2015). Gastrointestinal Dose-Histogram Effects in the Context of Dose-Volume - Constrained Prostate Radiation Therapy: Analysis of Data From the RADAR Prostate Radiation Therapy Trial. International Journal of Radiation Oncology Biology Physics, 91(3), 595-603. [More Information]
Betts, J., Mears, C., Reynolds, H., Tack, G., Leo, K., Ebert, M., Haworth, A. (2015). Optimised robust treatment plans for prostate cancer focal brachytherapy. Procedia Computer Science, 51(1), 914-923. [More Information]
Trada, Y., Kneebone, A., Paneghel, A., Pearse, M., Sidhom, M., Tang, C., Wiltshire, K., Haworth, A., Fraser-Browne, C., Martin, J. (2015). Optimizing Radiation Therapy Quality Assurance in Clinical Trials: A TROG 08.03 RAVES Substudy. International Journal of Radiation Oncology Biology Physics, 93(5), 1045-1051. [More Information]
DiFranco, M., Reynolds, H., Mitchell, C., Williams, S., Allan, P., Haworth, A. (2015). Performance assessment of automated tissue characterization for prostate H&E stained histopathology. Progress in Biomedical Optics and Imaging, 9420, 94200M. [More Information]
Denham, J., Steigler, A., Joseph, D., Lamb, D., Spry, N., Duchesne, G., Atkinson, C., Matthews, J., Turner, S., Kenny, L., et al (2015). Radiation dose escalation or longer androgen suppression for locally advanced prostate cancer? Data from the TROG 03.04 RADAR trial. Radiotherapy and Oncology, 115(3), 301-307. [More Information]
Ebert, M., Bulsara, M., Haworth, A., Kearvell, R., Richardson, S., Kennedy, A., Spry, N., Bydder, S., Joseph, D., Denham, J. (2015). Technical quality assurance during the TROG 03.04 RADAR prostate radiotherapy trial: Are the results reflected in observed toxicity rates? Journal of Medical Imaging and Radiation Oncology, 59(1), 99-108. [More Information]
Taylor, M., Yeo, U., Supple, J., Keehan, S., Siva, S., Kron, T., Pham, D., Haworth, A., Franich, R. (2015). The Importance of Quasi-4D Path-Integrated Dose Accumulation for More Accurate Risk Estimation in Stereotactic Liver Radiotherapy. Technology in Cancer Research and Treatment, 15(3), 428-436. [More Information]
Duchesne, G., Grand, M., Kron, T., Haworth, A., Corry, J., Jackson, M., Ng, M., Besuijen, D., Carter, H., Martin, A., Schofield, D., Gebski, V., et al (2015). Trans Tasman Radiation Oncology Group: Development of the Assessment of New Radiation Oncology Technology and Treatments (ANROTAT) Framework. Journal of Medical Imaging and Radiation Oncology, 59(3), 363-370. [More Information]

show 10 more

2014

Carter, H., Martin, A., Schofield, D., Duchesne, G., Haworth, A., Hornby, C., Sidhom, M., Jackson, M. (2014). A decision model to estimate the cost-effectiveness of intensity modulated radiation therapy (IMRT) compared to three dimensional conformal radiation therapy (3DCRT) in patients receiving radiotherapy to the prostate bed. Radiotherapy and Oncology, 112(2), 187-193. [More Information]
Pearse, M., Fraser-Browne, C., Davis, I., Duchesne, G., Fisher, R., Frydenberg, M., Haworth, A., Jose, C., Joseph, D., Woo, H., et al (2014). A Phase III trial to investigate the timing of radiotherapy for prostate cancer with high-risk features: background and rationale of the Radiotherapy - Adjuvant Versus Early Salvage (RAVES) trial. BJU International, 113(Suppl 2), 7-12. [More Information]
Reynolds, H., Williams, S., Zhang, A., Ong, C., Rawlinson, D., Chakravorty, R., Mitchell, C., Haworth, A. (2014). Cell density in prostate histopathology images as a measure of tumor distribution. Progress in Biomedical Optics and Imaging, 9041, 90410S. [More Information]
Ebert, M., Foo, K., Haworth, A., Gulliford, S., Kearvall, R., Kennedy, A., Richardson, S., Krawiec, M., Stewart, N., Joseph, D., et al (2014). Derivation and representation of dose-volume response from large clinical trial data sets: An example from the RADAR prostate radiotherapy trial. Journal of Physics: Conference Series, 489(1), 1-5. [More Information]
Melidis, C., Bosch, W., Izewska, J., Fidarova, E., Zubizarreta, E., Ulin, K., Ishikura, S., Followill, D., Galvin, J., Haworth, A., et al (2014). Global Harmonization of Quality Assurance Naming Conventions in Radiation Therapy Clinical Trials. International Journal of Radiation Oncology Biology Physics, 90(5), 1242-1249. [More Information]
Yahya, N., Ebert, M., Bulsara, M., Haworth, A., Kearvell, R., Foo, K., Kennedy, A., Richardson, S., Krawiec, M., Joseph, D., et al (2014). Impact of treatment planning and delivery factors on gastrointestinal toxicity: An analysis of data from the RADAR prostate radiotherapy trial. Radiation Oncology, 9(1), 1-10. [More Information]
Haworth, A., Paneghel, A., Bressel, M., Herschtal, A., Pham, D., Tai, K., Oates, R., Gawthrop, J., Cray, A., Foroudi, F. (2014). Prostate Bed Radiation Therapy: The Utility of Ultrasound Volumetric Imaging of the Bladder. Clinical Oncology, 26(12), 789-796. [More Information]
Ebert, M., Gulliford, S., Buettner, F., Foo, K., Haworth, A., Kennedy, A., Joseph, D., Denham, J. (2014). Two non-parametric methods for derivation of constraints from radiotherapy dose-histogram data. Physics in Medicine and Biology, 59(13), N101-N111. [More Information]

show 5 more

2013

Dempsey, C., Smith, R., Nyathi, T., Ceylan, A., Howard, L., Patel, V., Das, R., Haworth, A. (2013). ACPSEM brachytherapy working group recommendations for quality assurance in brachytherapy. Australasian Physical and Engineering Sciences in Medicine, 36(4), 387-396. [More Information]
Haworth, A., Wilfert, L., Butler, D., Ebert, M., Todd, S., Bucci, J., Duchesne, G., Joseph, D., Kron, T. (2013). Australasian brachytherapy audit: Results of the 'end-to-end' dosimetry pilot study. Journal of Medical Imaging and Radiation Oncology, 57(4), 490-498. [More Information]
Haworth, A., Butler, D., Wilfert, L., Ebert, M., Todd, S., Hayton, A., Kron, T. (2013). Comparison of TLD calibration methods for 192Ir dosimetry. Journal of Applied Clinical Medical Physics, 14(1), 258-272. [More Information]
Haworth, A., Ibbott, G. (2013). Medical Physics for Clinical Trials. In Jacob Van Dyk (Eds.), The Modern Technology of Radiation Oncology, Vol 3, (pp. 487-510). Madison, WI, United States: Medical Physics.
Ibbott, G., Haworth, A., Followill, D. (2013). Quality assurance for clinical trials. Frontiers in Oncology, 3, 1-11. [More Information]
Kearvell, R., Haworth, A., Ebert, M., Murray, J., Hooton, B., Richardson, S., Joseph, D., Lamb, D., Spry, N., Duchesne, G., et al (2013). Quality improvements in prostate radiotherapy: Outcomes and impact of comprehensive quality assurance during the TROG 03.04 'RADAR' trial. Journal of Medical Imaging and Radiation Oncology, 57(2), 247-257. [More Information]
Smith, R., Taylor, M., McDermott, L., Haworth, A., Millar, J., Franich, R. (2013). Source position verification and dosimetry in HDR brachytherapy using an EPID. Medical Physics, 40(11), 1-12. [More Information]
Papagiannis, P., Ballester, F., 60025709, C., Haworth, A., Ibbott, G., Mourtada, F., Rivard, M., Siebert, F., Sloboda, R., Thomson, R., et al (2013). SU‐E‐T‐509: DICOM Test Case Plans for Model‐Based Dose Calculations Methods in Brachytherapy. Medical Physics, 40(6), 322. [More Information]
Foo, K., Ebert, M., Carolan, M., Haworth, A., Bulsara, M., Joseph, D., Denham, J. (2013). TU‐G‐108‐06: Anatomical Localization of Late Rectal Toxicity Predictors in Prostate Radiotherapy. Medical Physics, 40(6), 454. [More Information]
Haworth, A., Williams, S., Reynolds, H., Waterhouse, D., Duchesne, G., Bucci, J., Joseph, D., Bydder, S., Ebert, M. (2013). Validation of a radiobiological model for low-dose-rate prostate boost focal therapy treatment planning. Brachytherapy, 12(6), 628-636. [More Information]

show 7 more

2012

Foroudi, F., Wilson, L., Bressel, M., Haworth, A., Hornby, C., Pham, D., Cramb, J., Gill, S., Tai, K., Kron, T. (2012). A dosimetric comparison of 3D conformal vs intensity modulated vs volumetric arc radiation therapy for muscle invasive bladder cancer. Radiation Oncology, 7(1), 111. [More Information]
Senthi, S., Gill, S., Haworth, A., Kron, T., Cramb, J., Rolfo, A., Thomas, J., Duchesne, G., Hamilton, C., et al (2012). Benchmarking dosimetric quality assessment of prostate intensity-modulated radiotherapy. International Journal of Radiation Oncology Biology Physics, 82(2), 998-1005. [More Information]
Nguyen, B., Hornby, C., Kron, T., Cramb, J., Rolfo, A., Pham, D., Haworth, A., Tai, K., Foroudi, F. (2012). Optimising the dosimetric quality and efficiency of post-prostatectomy radiotherapy: A planning study comparing the performance of volumetric-modulated arc therapy (VMAT) with an optimised seven-field intensity-modulated radiotherapy (IMRT) technique. Journal of Medical Imaging and Radiation Oncology, 56(2), 211-219. [More Information]
Mak, D., Gill, S., Paul, R., Stillie, A., Haworth, A., Kron, T., Cramb, J., Knight, K., Thomas, J., Duchesne, G., et al (2012). Seminal vesicle interfraction displacement and margins in image guided radiotherapy for prostate cancer. Radiation Oncology, 7(1), 1-9. [More Information]
Ebert, M., McDermott, L., Haworth, A., van der Wath, E., Hooton, B. (2012). Tools to analyse and display variations in anatomical delineation. Australasian Physical and Engineering Sciences in Medicine, 35(2), 159-164. [More Information]

show 2 more

2011

Roozen, K., Kron, T., Haworth, A., Franich, R. (2011). Evaluation of EBT radiochromic film using a multiple exposure technique. Australasian Physical and Engineering Sciences in Medicine, 34(2), 281-289. [More Information]
Fox, C., Kron, T., Leahy, M., Duchesne, G., Williams, S., Tai, K., Haworth, A., Herschtal, A., Foroudi, F. (2011). Interfraction patient motion and implant displacement in prostate high dose rate brachytherapy. Medical Physics, 38(11), 5838-5843. [More Information]
Hayton, A., Haworth, A., Waterhouse, D., Todd, S., Pillainayagam, J. (2011). Lack of backscatter factor measurements in HDR applications with MOSkins. Australasian Physical and Engineering Sciences in Medicine, 34(4), 545-552. [More Information]
Foroudi, F., Wong, J., Kron, T., Rolfo, A., Haworth, A., Roxby, P., Thomas, J., Herschtal, A., Pham, D., Williams, S., et al (2011). Online adaptive radiotherapy for muscle-invasive bladder cancer: Results of a pilot study. International Journal of Radiation Oncology Biology Physics, 81(3), 765-771. [More Information]

show 1 more

2009

Hickey-Moody, A., Haworth, R. (2009). Affective Literacies. In Masny, Diana; Cole, David R (Eds.), Multiple Literacies Theory: A Deleuzian Perspective, (pp. 79-91). Rotterdam, Netherlands: Sense Publishers. [More Information]

Selected Grants

2020

CRFI-Annette Haworth, Haworth A, DVC Research/CRFI-Frank Taylor - Bequest

2019

Cancer imaging and targeted radiation therapy: Innovation, discovery and translation, Keall P, O'Brien R, Nguyen D, Shieh C, Haworth A, Kuncic Z, Booth J, Eade T, Grieve S, Cancer Institute NSW/Translational Program Grant

2018

Purchase of a CIRS Dynamic Thorax Phantom (Model 008A)., Haworth A, Keall P, O'Brien R, National Health and Medical Research Council (NHMRC)/Equipment Grant

2017

Biofocussed prostate cancer RadioTherapy BiRT: A personalised approach to delivering the right dose to the right place, Haworth A, Williams S, Ebert M, Reynolds H, Dowling J, Betts J, Murphy D, National Health and Medical Research Council (NHMRC)/Project Grants

2015

Reducing the greatest uncertainty in radiotherapy, Holloway L, Haworth A, National Health and Medical Research Council (NHMRC)/Project Grants

2014

Radiotherapy treatment for prostate cancer - a change in practice based on direct evidence for targeting and toxicity effects using real outcomes data, Ebert M, Haworth A, National Health and Medical Research Council (NHMRC)/Project Grants
Funding for Chair Medical Physics, Haworth A, Thwaites D, Health Administration Corporation/Chair Medical Physics

In the media

http://oncologynews.com.au/first-patient-receives-flattening-filter-free-sabr-treatment-at-peter-mac/

http://www.dailymail.co.uk/news/article-2913354/Trials-underway-cut-two-months-cancer-radiation-treatment-single-visit-just-TEN-minutes.html

https://www.youtube.com/watch?v=27kxnmMR-dg

https://thepulse.org.au/2023/09/28/professor-annette-haworth-a-visionary-leader-for-radiation-oncology-in-western-sydney/

Faculty of Science

Page not found